News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Drug that targets ‘on switch’ in cancer cells moves one step closer
The new targeted therapy which could combat drug resistance has been found to be safe in early trials, allowing it to move to the next stage of development.
New class of drugs effective against one of the toughest cancers to treat
Scientists have discovered a promising new type of therapy for bile duct cancer – a deadly disease which in most cases is inoperable and incurable.
New blood test could quickly predict if the drug palbociclib will help breast cancer patients
Scientists say the test could detect in two to three weeks whether the drug is working, compared to the two to three months that it currently takes.
Celebrating courageous patients and research success
Discovery Club members at our annual Discovery Club reception recently heard first-hand about ovarian cancer treatment from cancer survivor Sue Vincent.
Growing replica tumours in the lab could personalise drug treatment for each patient
The exciting new technique involves growing ‘mini tumours’ from biopsy samples – and could help end reliance on trial and error in selecting cancer treatments.
Cancer researchers visit the Palace to receive major prize for pioneering precision medicine discoveries
The award acknowledges the ICR's outstanding contribution to the discovery of new cancer drugs – including pioneering the transition from one-size-fits-all chemotherapy to targeted drug treatment.
ICR childhood brain cancer research to benefit from funding boost announced by the Department of Health and Social Care and Cancer Research UK
Brain tumour research in the UK is set to be revolutionised with £45 million in funding by the Department of Health and Social Care and Cancer Research UK. The Institute of Cancer Research, London, will benefit from some of this new funding.
ICR teams up with Merck and Cancer Research UK on strategic drug discovery programme
The new alliance will take a strategic joint approach to drug discovery and build on previous successful collaborations on individual research projects.
Scientists reveal protein that all cells rely on to divide at the right time
ICR scientists have identified a cell cycle protein that is crucial to cell division, and whose location determines when cells begin to divide.
Sir Vince Cable MP visits The London Cancer Hub
Liberal Democrat leader Sir Vince Cable heard about exciting progress in delivery of The London Cancer Hub, and the challenges in taking advances in treatment to patients, during a visit to the ICR’s Sutton site.
Study opens up new way of treating rare cancer of arms and legs
The disease, called synovial sarcoma, showed unusual sensitivity to drugs that stop cells from repairing damage to their DNA.
Deal doubles land purchased for new London Cancer Hub
A new £14.1 million investment sets the stage for a site in Sutton, south London, to become the world’s leading hub for cancer research and treatment.
